CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy

PURPOSE: While tumor markers (carbohydrate antigen 19-9 [CA 19-9] and carcinoembryonic antigen [CEA]) can aid in the diagnosis of biliary tract cancer, their prognostic role has not been clearly elucidated. Therefore, this study was conducted to evaluate the prognostic role of tumor markers and tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dae-Won, Im, Seock-Ah, Kim, Yu Jung, Yang, Yaewon, Rhee, Jiyoung, Na, Im Il, Lee, Kyung-Hun, Kim, Tae-Yong, Han, Sae-Won, Choi, In Sil, Oh, Do-Youn, Kim, Jee Hyun, Kim, Tae-You, Bang, Yung-Jue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512384/
https://www.ncbi.nlm.nih.gov/pubmed/28111425
http://dx.doi.org/10.4143/crt.2016.326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512384/
https://www.ncbi.nlm.nih.gov/pubmed/28111425
http://dx.doi.org/10.4143/crt.2016.326

Ejemplares similares